Quality of Life and Supportive Care in Multiple Myeloma

@inproceedings{Cmert2013QualityOL,
  title={Quality of Life and Supportive Care in Multiple Myeloma},
  author={Melda C{\"o}mert and Ajda Ersoy G{\"u}neş and Fahri Şahin and G{\"u}ray Saydam},
  booktitle={Turkish journal of haematology : official journal of Turkish Society of Haematology},
  year={2013}
}
UNLABELLED Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality of life with effective supportive care. Supportive treatment is an essential part of the therapeutic management of myeloma patients because it is directed towards improving the patient's quality of life and also can improve survival. The… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

MMSA-1 expression pattern in multiple myeloma and its clinical significance

  • Clinical and Experimental Medicine
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 61 REFERENCES

Supportive care in multiple myeloma.

  • Best practice & research. Clinical haematology
  • 2007
VIEW 16 EXCERPTS
HIGHLY INFLUENTIAL

Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2011
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…